Topic
Microbiome
The microbiome community — R&D leaders, translational scientists and business-development teams — building the next generation of microbiome-informed therapeutics.
- Microbiome and the biological clock
- Cognition, metabolism and immunity
- Business development and partnering
About Microbiome at Global Engage
Microbiome science has matured from correlation studies to a genuine therapeutic modality. FDA approvals of live biotherapeutic products have unlocked a wave of investment and industrial focus, and the field is now working through the practicalities of manufacturing, delivery, patient stratification and reimbursement at scale.
Global Engage's microbiome series — including Probiota Global, Americas and Asia — is the community's principal meeting point. R&D leadership, translational teams, ingredient and platform partners, and the investors backing them share a room for two intense days.
The programme spans the gut-brain axis, metabolic and immune indications, next-generation sequencing and multi-omics, live biotherapeutic manufacturing, and the business-development track that has quietly become the industry's default partnering venue.
Upcoming Microbiome conferences
Microbiome R&D & Business Collaboration Forum: USA
How microbial ecosystems shape the biological clock.
- Dates
- 1–2 Oct 2026
- Location
- San Diego, USA
FAQs
Microbiome at Global Engage — questions we hear most
Get the briefing
Stay ahead in Microbiome
Monthly updates on upcoming conferences, new research and industry moves in this space.